This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: The Wistar Institute. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations in Melanoma Treatment by Rajasekharan Somasundaram
Introduction
Rajasekharan Somasundaram is a notable inventor based in West Chester, PA, who has made significant contributions to the field of melanoma treatment. His innovative work focuses on developing methods and compositions that enhance the effectiveness of therapies for this challenging form of skin cancer.
Latest Patents
Somasundaram holds a patent for "Methods and compositions for treating melanoma." This patent includes compositions that feature BRAF-based peptides, which can be used alone or in combination with T helper peptides. Additionally, the patent covers nucleic acid sequences encoding these BRAF-based peptides, as well as dendritic cells that have been pretreated with these peptides. The compositions are designed to be useful in treating melanoma, particularly when co-administered with antibodies to checkpoint inhibitors or similar molecules.
Career Highlights
Somasundaram is affiliated with The Wistar Institute of Anatomy & Biology, where he conducts research aimed at improving treatment options for melanoma patients. His work is characterized by a commitment to advancing medical science and providing new hope for those affected by this disease.
Collaborations
Some of his notable coworkers include Meenhard Herlyn and Dorothee Herlyn, who collaborate with him in research efforts to further explore innovative treatment strategies for melanoma.
Conclusion
Rajasekharan Somasundaram's contributions to melanoma treatment through his patented methods and compositions highlight the importance of innovation in medical research. His work continues to pave the way for new therapeutic approaches that could significantly impact patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
